“We’re extremely proud to have the HEI designation six years in a row and to be the leader in the state of Connecticut as the only stand-alone fertility center with this appointment,” says Robin Mangieri, CEO of Illume Fertility.

NORWALK, Conn. (PRWEB)
April 05, 2022

Today, Illume Fertility (formerly RMA of Connecticut), a leading modern fertility practice, announced their “LGBTQ Healthcare Equality Leader” designation from the Human Rights Campaign Foundation (HRC) for 2022, marking their sixth year earning the designation. The designation was awarded in the 15th edition of HRC’s Healthcare Equality Index (HEI), released in March 2022. A record 906 healthcare facilities actively participated in the Healthcare Equality Index 2022 survey, with HRC Foundation evaluating key policies at 2,200 healthcare facilities nationwide. Of those included in the HEI, 496 earned an “LGBTQ Healthcare Equality Leader” designation. Illume Fertility was the only free-standing fertility center given the HEI designation in New England.

“We’re extremely proud to have the HEI designation six years in a row and to be the leader in the state of Connecticut as the only stand-alone fertility center with this appointment,” says Robin Mangieri, CEO of Illume Fertility. “We’ve dedicated resources to making sure we meet these standards year after year and we are committed to providing inclusive care to our LGBTQ patients.”

The 15th edition of the HEI assesses participants on four criteria: Non-Discrimination and Staff Training, Patient Services and Support, Employee Benefits and Policies, and Patient and Community Engagement.

In the 2022 report, an impressive 496 facilities earned HRC’s “LGBTQ Health Care Equality Leader” designation, receiving the maximum score in each section and earning an overall score of 100. With 82 percent of participating facilities scoring 80 points or more, health care facilities are demonstrating concretely that they are going beyond the basics when it comes to adopting policies and practices in LGBTQ care.

The remarkable progress reflected in the 2022 HEI includes:

• More than half of HEI participants now have written gender transition guidelines;
• 81 percent of hospitals surveyed offer trans-inclusive benefits — an impressive six percentage-point increase compared to last year, which bring hospitals on par with their corporate counterparts, as measured by HRC’s 2022 CEI;
• A 112 percent increase in training hours recorded — clocking in at more than 200,000 hours of LGBTQ care training provided;
• 81 percent of HEI participants’ electronic health records capture a patient’s sexual orientation, and 90 percent of participants’ electronic health records capture a patient’s gender identity.

About Illume Fertility

Illume Fertility, formerly RMA of Connecticut, is a leading modern fertility practice with an exceptional patient experience, providing care, guidance, and expertise to help patients achieve their fertility and family-building goals. Led by an award-winning team of eight highly credentialed Board Certified reproductive endocrinologists, many of whom have received Castle Connolly’s prestigious Top Doc award, Illume Fertility specializes in a range of assisted reproductive technologies (ART) including intrauterine insemination (IUI), in-vitro fertilization (IVF), preimplantation genetic testing (PGT), and Invocell (IVC). Illume Fertility’s internationally recognized Gay Parents To Be® program specializes in LGBTQ+ family building. For the last five years, Illume Fertility has been recognized as a Leader in Healthcare Equality by the Human Rights Campaign. Illume Fertility is one of the largest fertility clinics and egg donation centers in the region, offering egg freezing, oncofertility preservation, and PCOS management, helping patients as young as 16. Illume Fertility is the only regional fertility clinic offering on-site holistic patient support services including nutrition counseling, individual and couples psychological counseling, acupuncture and yoga.

About The Human Rights Campaign Foundation

The Human Rights Campaign Foundation is the education arm of America’s largest civil rights organization working to achieve equality for lesbian, gay, bisexual, transgender and queer people. HRC envisions a world where LGBTQ people are embraced as full members of society at home, at work and in every community.

Share article on social media or email:

“ColoWrap has been a huge satisfaction driver for our endoscopy staff and providers,” said Cheryl Langford, Director Surgical Services & Endoscopy at Northfield Hospital. “Musculoskeletal pain and fatigue the team has experienced associated with colonoscopy has been significantly reduced.”

DURHAM, N.C. (PRWEB)
April 05, 2022

ColoWrap, LLC., the early-stage medical technology company behind the first and only anti-looping colonoscopy compression device, today announced two abstracts highlighting the technology’s ability to reduce procedure time and address ergonomic risks during colonoscopy that were selected for presentation during the Society for American Gastrointestinal and Endoscopic Surgeons (SAGES) 2022 Annual Meeting. SAGES 2022 was held from March 16 through March 19 in Denver, Colorado.

Colonoscopy remains the gold standard for colorectal screening and prevention with over 19 million procedures conducted annually in the United States. Looping during colonoscopy remains the largest barrier to delivering colonoscopies safely and efficiently. The status quo to reduce looping, including manual abdominal pressure and patient repositioning, introduces unique ergonomic challenges and increases the risk for musculoskeletal (MSK) injury amongst endoscopy staff. Torquing associated with loop reduction is also a contributor to ergonomic strain in physicians.

Presented as part of the SAGES’ “Next Big Thing” session was “ColoWrap Colonoscopy Compression Device Shortens Procedure Time and Increases Physician and Staff Satisfaction.” Research was conducted at Northfield Hospital located in Northfield, Minnesota. The hospital self-reported that 60% of endoscopy personnel had experiences injuries, strains, or MSK pain attributed to applying manual pressure and repositioning patients during colonoscopy. Of those experiencing pain, 20% of endoscopy staff reported that they suffer daily MSK pain due to the requirements of manual abdominal pressure and patient repositioning during colonoscopy.

At Northfield, ColoWrap use reduced average cecal intubation time by 3.6 minutes and reduced procedure time by 5 minutes per case. There was also a 48% reduction in manual pressure and a 79% reduction in patient repositioning. All endoscopy personnel reported moderate to very significant reductions in MSK pain and general fatigue while physicians reported reductions in looping and personal physical strain, as well as improved patient comfort. (Gross, S., Langford, C., & Lusk, A., 2022)

“ColoWrap has been a huge satisfaction driver for our endoscopy staff and providers,” said Cheryl Langford, MSN, RN, CNOR, Director Surgical Services & Endoscopy at Northfield Hospital. “Musculoskeletal pain and fatigue the team has experienced associated with colonoscopy has been significantly reduced.”

Also selected for presentation, “Preventing Staff Injury and Enhancing Satisfaction: Results from Use of ColoWrap Colonoscopy Compression Device in High-Volume Endoscopy Unit,” highlights research conducted at Barnes Jewish West County Hospital, where 85% of endoscopy personnel had experienced MSK pain or injury related to applying manual pressure or repositioning patients during colonoscopy.

“The use of ColoWrap in my department has been a tremendous benefit to our staff and patients.” said Connie Hall, BSN, RN, CGRN at Barnes Jewish West County Hospital. “Staff don’t complain about hand, back, and shoulder pain nearly as much. On a recent survey on safety, my department scored very high on questions about whether the facility cares about the safety of the staff,” Hall continued. “Using ColoWrap was pointed out as something done to protect staff from potential injuries on the job. I also feel it is much safer for our patients. I have not had any reports of abdominal pain or bruising from patients since we started using ColoWrap.”

This single-center observational study focused on patients at risk for difficult colonoscopy, including those with a BMI >35, prior difficult colonoscopy, abdominal hernia, or multiple prior abdominal surgeries. In the study, ColoWrap reduced the use of manual abdominal pressure and patient repositioning by 73.6%, and 59.5%, respectively. 100% of staff reported significant to very significant reduction in MSK pain, general fatigue, cecal intubation time, and the frequency of prolonged colonoscopies. Interestingly, staff also reported a significant improvement in their ability to focus on other procedural duties during colonoscopy due to the need for manual pressure and repositioning being drastically reduced. (Gross, S., Wang, J., Hall, C. & Eason, B., 2022)

Collectively, this research was led by Dr. Seth Gross (NYU Langone Medical Center) and Dr. Jean Wang, MD, PhD (Washington University in St. Louis), in collaboration with Cheryl Langford, MSN, RN, CNOR (Northfield Hospital), Amber Lusk, MSN, RN, CNOR (Northfield Hospital), Connie Hall, BSN, RN, CGRN (Barnes Jewish West County Hospital), and Blair Eason, RN (Barnes Jewish West County Hospital).

About ColoWrap, LLC.

ColoWrap® is an early-stage medical technology Company dedicated to creating a Zero Harm Endoscopy Environment. The Company’s flagship product, the ColoWrap Anti-Looping Colonoscopy Compression Device is the first and only non-invasive device that has been clinically proven to mitigate looping during colonoscopy. Worn by the patient during the exam, the device applies targeted, adjustable abdominal pressure to minimize sigmoid and transverse looping. In clinical trials, ColoWrap has been shown to shorten procedure time, improve patient comfort, and reduce staff-reported musculoskeletal pain by 85%. Learn more at https://www.colowrap.com

Follow ColoWrap on LinkedIn, Twitter, Facebook, and Instagram.

References:

1. Gross, S., Langford, C., & Lusk, A. (2022, March 18). ColoWrap Colonoscopy Compression Device Shortens Procedure Time and Increases Physician and Staff Satisfaction, SAGES Conference, Denver, CO. https://eventpilot.us/web/page.php?page=IntHtml&project=SAGES22&id=121734

2. Gross, S., Wang, J., Hall, C. & Eason, B. (2022, March 18). Preventing Staff Injury and Enhancing Satisfaction: Results from Use of ColoWrap Colonoscopy Compression Device in High-Volume Endoscopy Unit, SAGES Conference, Denver, CO. https://epostersonline.com/sages2022/poster/etp421?view=true

AUSTIN, Texas (PRWEB)
April 05, 2022

On a mission to destigmatize sexual health, Giddy, the world’s largest sexual health resource, has grown to reach 2.8 million users during their first year of launch. Empowering the public to take control of their sexual wellbeing, Giddy has recently launched the first of its kind all-encompassing sexual health telehealth service offering convenient, affordable and high-quality virtual healthcare.

“We are in the midst of a sexual health revolution,” says Brett Jacobson, Founder and CEO of Giddy. “We created Giddy to make a positive impact of people’s lives and it is exciting to see the millions of people who have discovered us over the past year. As we are building Giddy to be the most comprehensive sexual health platform, direct access to sexual health doctors and specialists is an important service we are excited to offer our readers.”

Licensed doctors and specialists are available on-demand for common sexual health diagnosis such as UTIs, consults on sex health topics such as erectile dysfunction or birth control, to get help managing a STI, as well as to discuss conditions, diseases, disorders, mental health and more. Powered by Sesame Telehealth, users are able to choose their provider at self-pay prices without insurance.

Over the past year, Giddy’s award-winning team of journalists have added more than 3,100 free articles, its already robust database of sexual health information, keeping readers up to date with the latest news, clearing up myths and misconceptions, and delivering easily digestible, thoroughly researched and medically-reviewed information covering the wide breadth of sexual health. Four articles received industry accolades winning a Digital Health Award including Unequal Access, Unequal Outcomes: Race and Prostate Cancer, Alice in Wonderland Syndrome: The Unsettling Symptoms of Migraines, Condom Sales are Skyrocketing for Hot Vax Summer and Why Does Getting Knocked in the Balls Hurt So Much.

Helping to further raise awareness, Giddy organized panel discussions at major festivals and events such as SXSW, and brought together recognizable faces such as AnnaLynn McCord, Tom Arnold, Chris “Kid” Reid, Katie Haan and more to share their own personal life experiences to encourage others who may be dealing with similar challenges in their BARE video series. In getting candid about sex, Giddy launched Well, IMO, which features influencers from all walks of life who get frank about issues that matter from dating to difficult pregnancies, safe sex practices, fertility and more.

About Giddy: Illuminating sexual wellbeing for all, Giddy is the world’s largest sexual health resource. Their team of award-winning journalists cover over 120 topics from conditions, diseases and disorders to stages of life, relationships, and much more with medically-reviewed, engaging content. Giddy is a 2021 Digital Health Award winner. To become a free member visit http://www.getmegiddy.com

Share article on social media or email:

While diabetes, hypertension, and respiratory tract infection are slated for significantly increased testing, decentralized clinical trial design is expected to increase 28% this year over 2021.

Technology platforms partnered with a systems integrator, can accelerate data collection and provide both better integration of the disparate software and data systems involved and platform-level unification of the entire CT process.

MANASSAS, Va. (PRWEB)
April 05, 2022

Clinical trials in certain common serious diseases are on track for their first year-over-year increase since the outbreak of the COVID-19 pandemic. Among areas slated for significantly increased testing are diabetes, hypertension, and respiratory tract infection. Along with these activities will come a marked increase in decentralized clinical trial design, expected to increase 28% this year over 2021.(1) “By joining forces to enable the increased growth of decentralized studies,” says Dr. Harsha Rajasimha, founder and CEO of Jeeva Informatics, “technology companies are transforming the face of medical research. The remotely managed, decentralized clinical trial is the wave of the future.”

One reason for this, notes Dr. Rajasimha, is the ongoing lack of diversity among patients participating in traditionally structured clinical trials. Historically, clinical trials have tended to take place in close proximity to major medical research organizations; some 50% of FDA trials are conducted in one to two percent of all US zip codes,(2) leading to under-representation of members of racial or ethnic minorities.(3) The solution, says Dr. Rajasimha, is to allow socio-economically and geographically diverse patients to participate in clinical trials independent of their location via a modular and flexible bring-your-own-device solution.

There has been, he notes, a growing awareness of the need for decentralized clinical trials for some time. A few years back, for example, the National Academies of Sciences convened a forum on transforming clinical trials through technology. Various speakers took note that:

• 
      The traditional research model requires a massive investment of resources before acquiring any feedback on study viability.
•     New technology such as wearable devices, remote monitoring, and virtual clinical visits could make Clinical Trials more patient-focused.
•     Social media offer increased opportunities for patient engagement.(4)

For decentralized clinical trials to work effectively, however, says Dr. Rajasimha, it is necessary for the various technologies involved to work together effectively. Companies like Jeeva Informatics are developing the next generation of virtual platform technology that gives sponsors and CROs, greater flexibility with a modular eClinical platform for global trial operations.

Lessons learned

•     Over the course of the COVID-19 pandemic, says Dr. Rajasimha, it has become clear in a number of ways that remote access to clinical trials is essential.
•     The pandemic has made many prospective enrollees unable or unwilling to travel to a hospital or other major medical facility to participate in a new drug study.
•     A large percentage of CTs will experience delays, costing the developers as much as $1 million per day.(5)
•     Traditional trials have led to a serious lack of diversity.
•     The accelerated process used for COVID-19 trials has conclusively demonstrated both the need for and the efficacy of decentralized clinical trials.

Technology platforms partnered with a systems integrator, says Dr. Rajasimha, can accelerate data collection and provide both better integration of the disparate software and data systems involved and platform-level unification of the entire CT process. What is needed, he says, is the ability to knit patient outcomes—from virtually any device—into an integrated 360o view.

In fact, adds Rajasimha, the last few years have seen an enormous increase in how technology is applied to clinical trials. The use of Artificial Intelligence technology in matching patients to clinical trials, in diagnostic devices, the proliferation of smartphone use in clinical data-capture, cloud services to store and access to Electronic Medical Records and “many more examples have led to one inescapable conclusion: clinical trials can now be conducted entirely in a virtual format.” There are many challenges still to conquer, Rajasimha notes, but eliminating the need for in-person interaction coupled with real-time access to data are encouraging news for the future of clinical trials.

“On one level,” says Dr. Rajasimha, “a clinical trial is a one-off project—a test of the response of X subjects to Y treatment. On another level, however, it needs to be a comprehensive digital data collection and processing platform. Being a part of the Amazon Partner Network (APN) and a recent partnership with a global IT systems integrator, enables us to achieve both data collection and process unification, thus delivering dramatic improvements in cost- and performance-effectiveness to the sponsors of clinical trials.”

About Jeeva Informatics

The personal experience of losing a child born with a rare disease and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of postdoctoral training at NIH and FDA to accelerating therapies for rare and common conditions. He knew that technology in itself is not the limiting factor and that patient-centered design guided by stakeholder needs and regulatory requirements would guide their continuous learning digital platform. By digitizing and automating manual repetitive tasks and reducing the logistical burdens on patients and study teams by over 70%, Jeeva accelerates the process of bringing new medicines or vaccines to patients who need them by over 3x faster. The Virginia-based company’s modular software-as-a-service platform is fully scalable and facilitates patient enrollment, engagement, and evidence generation in clinical trials on any browser-enabled mobile device. Visit https://jeevatrials.com/

1.    Castañeda, et al. “2022 Forecast: Diabetes, Cardiovascular, Respiratory Trial Activity Set to Rebound.” Clinical Trials Arena, 3 Feb. 2022, clinicaltrialsarena.com/analysis/2022-clinical-trials-diabetes-cardiovascular-disease-among-likely-winners/.

2.    “Clinical Trials Have Far Too Little Racial and Ethnic Diversity.” Scientific American, 1 Sept. 2018, scientificamerican.com/article/clinical-trials-have-far-too-little-racial-and-ethnic-diversity/.

3.    “Why We Need to Improve Diversity in Clinical Trial Participants.” Mdgroup, 18 Dec. 2021, mdgroup.com/blog/why-we-need-to-improve-diversity-amongst-clinical-trial-participants/#:

4.    Forum on Neuroscience and Nervous System Disorders. “Transforming Clinical Trials with Technology.” Neuroscience Trials of the Future: Proceedings of a Workshop., U.S. National Library of Medicine, 19 Aug. 2016, ncbi.nlm.nih.gov/books/NBK396107/.

5.    “How to Avoid Costly Clinical Research Delays: Blog.” MESM, mesm.com/blog/tips-to-help-you-avoid-costly-clinical-research-delays/.

Share article on social media or email:

We’re thrilled about the addition of NY Best Medical to our Partner Connect program, as it offers HHAeXchange users direct access to a top-tier HR and compliance solution.

NEW YORK (PRWEB)
April 05, 2022

NY Best Medical Care, PC, a leader in homecare industry compliance and HR programs, announced today that it has successfully launched their integration with the HHAeXchange platform through the HHAeXchange Partner Connect program. Partner Connect is an exclusive partner community that provides HHAeXchange customers with direct integrations to industry-leading solutions that streamline homecare agency operations and improve caregiver satisfaction.

“NY Best Medical uses new age technology and logistics to service the home care industry with a personalized innovative approach that has a proven success rate,” said Anatoliy Binshteyn, CEO of NY Best Medical Care. “Integration with HHAeXchange will help remove HR and compliance obstacles with an automated process at your fingertips.”

HHAeXchange Partners are a select group of solution providers that have proven experience building innovative software solutions for home and community-based services (HCBS). NY Best Medical Care is available to HHAeXchange customers today via Partner Connect, allowing for a seamless integration.

“From day one, it has been our goal to simplify all aspects of homecare management for our customers,” said Stephen Vaccaro, President of HHAeXchange. “We’re thrilled about the addition of NY Best Medical to our Partner Connect program, as it offers HHAeXchange users direct access to a top-tier HR and compliance solution.”

NY Best Medical Care, PC will manage agency employees’ physicals and compliance programs. Agencies will receive a customized plan developed by NY Best Medical’s experienced compliance consultants to help meet their agency’s organizational requirements. Additionally, agencies will be able to choose which services best suit the needs of their organization.

For more information on the HHAeXchange Partner Connect program and to learn more about NY Best Medical Care solutions, visit https://hhaexchange.com/nybestmedicalcare-partner/

About NY Best Medical Care, PC:

NY Best Medical Care, PC, is an accredited private medical practice providing quality care for a wide variety of home care agency needs. Our services range from employment physical exams, vaccinations (such as TB and MMR boosters), to drug testing and telehealth services, HR maintenance, and compliance, as well as being the glue that keeps it all running smoothly for your organization.

About HHAeXchange:

Founded in 2008, HHAeXchange is the leading technology platform for homecare and self-direction program management. Developed specifically for Medicaid home and community-based services (HCBS), HHAeXchange connects state agencies, managed care payers, providers, and caregivers through its intuitive web-based platform, enabling unparalleled communication, transparency, efficiency, and compliance. For more information, visit hhaexchange.com or follow the company on Twitter, LinkedIn and Facebook.

Share article on social media or email:

Dr. Daniel Chan is Memorial Healthcare System’s chief of orthopaedic surgery and sports medicine.

“The robotic arm facilitates the multiple cuts necessary for knee replacement based on patient-specific anatomical landmarks and soft tissue tension, while providing real-time intra-operative data that guides decision-making.”

HOLLYWOOD, Fla. (PRWEB)
April 05, 2022

With 900,000 knee replacements being performed in the United States each year, patients and surgeons alike are seeking the latest technology as they aim for improved outcomes, including greater mobility, less discomfort and a more rapid recovery. The award-winning surgeons at Memorial Orthopaedic Surgery and Sports Medicine Center are the first in South Florida to use the VELYS™ Robotic-Assisted Solution, a technology that helps them perform knee replacement surgery tailored to each patient’s unique anatomy to increase mobility, decrease pain and minimize recovery time, so patients can confidently return to their normal, active lifestyle sooner.

“This new robotic technology allows us to offer greater precision in terms of implant placement and soft tissue balancing for our patients, all in the hopes of improving patient outcomes,” said Dr. Daniel Chan, chief of Orthopaedic Surgery and Sports Medicine, Memorial Healthcare System. “The robotic arm facilitates the multiple cuts necessary for knee replacement based on patient-specific anatomical landmarks and soft tissue tension, while providing real-time intra-operative data that guides decision-making. Unlike other systems, the VELYS platform is completely image-less and does not require patients to go through the expense and radiation exposure of a pre-operative CT scan.”

It is estimated that 15% of current knee replacement patients are not fully satisfied after surgery due to persistent pain, stiffness, or instability. Every patient is unique and every knee is different; therefore orthopaedic surgeons at Memorial Regional Hospital South are using the VELYS™ Robotic-Assisted Solution to provide a patient-specific knee replacement surgical plan without the limitations of manual instrumentation. The use of the robot allows very precise adjustments in implant orientation and alignment to achieve a balanced knee throughout a full arc of motion with minimal soft tissue releases. This results for a more natural-feeling knee for the patient while also facilitating a rapid recovery.

“The Rehabilitation Institute at Memorial Regional Hospital South is poised to combine new technologies in complex orthopaedic surgeries with intensive rehabilitation to ensure our patients benefit from the continuum of care offered by our multidisciplinary teams – from diagnosis to surgery to rehabilitation and recovery,” said Doug Zaren, CEO, Memorial Regional Hospital South. “Our goal with every patient is to take them beyond their previous limitations into an active life in motion.”

Robotic-assisted knee replacement patients typically experience less pain and a faster recovery than traditional knee replacement surgery. Patients are encouraged to take the first step by scheduling a consultation with one of Memorial’s orthopedic specialists at 954-546-8902.

Memorial Orthopaedic Surgery and Sports Medicine Center is a fully-integrated, multi-disciplinary program based at Memorial Regional Hospital South consisting of specialists in orthopaedic surgery, primary care sports medicine, sports physiatry, cardiology, and sports medicine physical therapy. The program provides injury care, treatment for chronic musculoskeletal conditions, and routine checkups that include cardiac screening for athletes, performing artists, first responders and other active adults.

Memorial Regional Hospital South also houses Memorial Rehabilitation Institute, providing a wide array of inpatient and outpatient rehabilitation services to help maximize results. The team of specialists provides assessment, personalized treatment program development and progress monitoring for a variety of conditions, including stroke, brain injury, spinal cord injury, amputation, multiple trauma, neurologic conditions and multiple orthopaedic conditions.

Share article on social media or email:

G-CON expands its product portfolio with the acquisition of Panelco/ Plasteurop SAS a leading cleanroom component manufacturer

The joint vision and values of the companies and combined product portfolio will advance our market leadership as total cleanroom infrastructure provider.

COLLEGE STATION, Texas (PRWEB)
April 05, 2022

G-CON Manufacturing, Inc. has acquired Plasteurop, a leading France-based manufacturer of critical cleanroom components. Plasteurop’s core competence is the automated production of monolithic cleanroom wall panels and doors. These components are used in a variety of industries with stringent standards for cleanliness and quality. Plasteurop was founded in 1978 and acquired by Panelco SAS in 2004. Since then, the company has produced numerous highly innovative products and has received multiple awards for innovations in the cleanroom infrastructure market.

“We have enjoyed working with Plasteurop on many projects and have been impressed by their robust delivery timelines and high quality of the supplied components,” stated Maik Jornitz, President and CEO of G-CON. “This acquisition is a natural progression, adding these critical components into our product portfolio so we are able to serve our customer base with a broader range of bioprocess space infrastructures. The vertical integration of these cleanroom components will also accelerate our already rapid delivery times and enhance the delivery schedule certainty, all to the benefit of the global patient.”    

Plasteurop will become G-CON Clean Components SAS, with Philippe Calland remaining as the President of the independent subsidiary.

“Our desire is to accelerate the growth and further the innovative power of Panelco by joining G-CON, which we see as industry transforming prefabricated cleanroom supplier. The joint vision and values of the companies and combined product portfolio will advance our market leadership as total cleanroom infrastructure provider,” said Philippe Calland, President of Panelco. “This enables us to deliver sustainable healthcare processing spaces faster and in a much more cost-effective way.”

About G-CON Manufacturing, Inc.

G-CON Manufacturing designs, builds and installs prefabricated G-CON POD® cleanrooms. G-CON’s POD portfolio provides cleanrooms in a number of dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. G-CON POD® cleanroom units surpass traditional cleanroom structures in scalability, mobility and the possibility of repurposing the PODs once the production process reaches its lifecycle end. For more information, please visit G-CON’s website at http://www.gconbio.com. G-CON Manufacturing… BUILDING FOR LIFE™

About Panelco SAS

Panelco founded in 1978 and based in Vonnas near Lyon (France) is a leader in manufacturing of high-quality cleanroom wall and ceiling panels, windows and doors. Panelco supplies a variety of European cleanroom installers serving different types of industries with a wide variety of innovative cleanroom components.

For more information, please visit http://www.plasteurop.com

Share article on social media or email: